Feng‐Chih Shen

机构：Chang Gung University, Kaohsiung Chang Gung Memorial Hospital · ORCID：0000-0002-9936-6074

发表论文 37 篇 · 总被引 4542 次 · h-index 15

代表论文

• Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial (2019 · The Lancet · 被引 3179)
• Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial (2019 · The Lancet · 被引 645)
• Glucagon-like peptide 1 improves insulin resistance in vitro through anti-inflammation of macrophages (2016 · Brazilian Journal of Medical and Biological Research · 被引 111)
• The Causal Role of Mitochondrial Dynamics in Regulating Insulin Resistance in Diabetes: Link through Mitochondrial Reactive Oxygen Species (2018 · Oxidative Medicine and Cellular Longevity · 被引 85)
• Effects of Resistance Exercise on Glycated Hemoglobin and Functional Performance in Older Patients with Comorbid Diabetes Mellitus and Knee Osteoarthritis: A Randomized Trial (2019 · International Journal of Environmental Research and Public Health · 被引 55)
• Chaperonin counteracts diet-induced non-alcoholic fatty liver disease by aiding sirtuin 3 in the control of fatty acid oxidation (2023 · Diabetologia · 被引 45)